Related Experiment Video
Updated: May 27, 2026
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Laser treatment for retinopathy of prematurity
Samuel K Houston1, Charles C Wykoff, Audina M Berrocal
1Bascom Palmer Eye Institute, University of Miami School of Medicine, 900 North West 17th Street, Miami, FL 33136, USA. shouston@med.miami.edu
Insights
Laser photocoagulation effectively treats retinopathy of prematurity (ROP) by ablating the avascular retina, reducing unfavorable outcomes and preserving visual acuity in premature infants.
Area of Science:
- Ophthalmology
- Neonatology
- Developmental Biology
Background:
- Premature delivery can disrupt retinal development, causing retinopathy of prematurity (ROP), a leading cause of childhood blindness.
- The avascular retina is a key driver of ROP progression and associated vision loss.
Purpose of the Study:
- To review the application of laser photocoagulation in managing retinopathy of prematurity.
- To emphasize the importance of timely intervention for threshold and high-risk prethreshold ROP.
Main Methods:
- Review of existing literature on laser photocoagulation for ROP treatment.
- Analysis of treatment protocols focusing on complete avascular retina ablation.
Main Results:
- Laser photocoagulation of the avascular retina reduces unfavorable anatomic outcomes.
- Effective treatment involves confluent laser spot density, avoiding skip lesions to maintain visual acuity.
Conclusions:
- Early identification and treatment of ROP are crucial for improving visual outcomes.
- Laser photocoagulation is a vital therapeutic strategy for ROP, requiring precise application to the avascular retina.
Abstract:
Retinal development involves a complex coordination of events that may be affected by premature delivery, leading to retinopathy of prematurity (ROP), a potential blinding childhood disease. The avascular retina drives further disease progression, with laser ablation reducing unfavorable anatomic outcomes as well as maintaining visual acuity. Trials have stressed the importance of early identification and treatment of threshold and high-risk prethreshold disease to improve outcomes. Retinal ablation with laser photocoagulation should involve entire treatment of avascular retina with a confluent laser spot density, avoiding skip lesions. The current review highlights the use of laser photocoagulation in the treatment of ROP.
